Hear from Chief Scientific Officer Richard Buick, PhD, as he presented on behalf of Fusion Antibodies at the Antibody Engineering and Therapeutics conference, 2025.

likes

•

questions

•

company answers

Ask a question

Your question will be sent privately to Fusion Antibodies plc. The company may choose to make this question public.

Investor Q&As

Start the conversation

Ask Fusion Antibodies plc a question about this update.